Differential pharmacology and benefit/risk of azilsartan compared to other sartans
Theodore W Kurtz1, Takashi Kajiya21Department of Laboratory Medicine, University of California, San Francisco, CA, USA ; 2Department of Cardiovascular, Respiratory, and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, JapanAbstract: Azilsartan, an angiotensin II type...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-02-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/differential-pharmacology-and-benefitrisk-of-azilsartan-compared-to-ot-a9370 |